Clinical and virological findings in patients with Usutu virus infection, northern Italy, 2018.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Nov 2019
Historique:
entrez: 28 11 2019
pubmed: 28 11 2019
medline: 11 8 2020
Statut: ppublish

Résumé

BackgroundUsutu virus (USUV) is a mosquito-borne flavivirus, which shares its transmission cycle with the phylogenetically related West Nile virus (WNV). USUV circulates in several European countries and its activity has increased over the last 5 years.AimTo describe human cases of USUV infection identified by surveillance for WNV and USUV infection in the Veneto Region of northern Italy in 2018.MethodsFrom 1 June to 30 November 2018, all cases of suspected autochthonous arbovirus infection and blood donors who had a reactive WNV nucleic acid test were investigated for both WNV and USUV infection by in-house molecular methods. Anti-WNV and anti-USUV IgM and IgG antibodies were detected by ELISA and in-house immunofluorescence assay, respectively; positive serum samples were further tested by WNV and USUV neutralisation assays run in parallel.ResultsEight cases of USUV infection (one with neuroinvasive disease, six with fever and one viraemic blood donor who developed arthralgia and myalgia) and 427 cases of WNV infection were identified. A remarkable finding of this study was the persistence of USUV RNA in the blood and urine of three patients during follow-up. USUV genome sequences from two patients shared over 99% nt identity with USUV sequences detected in mosquito pools from the same area and clustered within lineage Europe 2.ConclusionsClinical presentation and laboratory findings in patients with USUV infection were similar to those found in patients with WNV infection. Cross-reactivity of serology and molecular tests challenged the differential diagnosis.

Identifiants

pubmed: 31771697
doi: 10.2807/1560-7917.ES.2019.24.47.1900180
pmc: PMC6885746
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
Immunoglobulin G 0
Immunoglobulin M 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Euro Surveill. 2019 Jan;24(3):
pubmed: 30670139
J Clin Microbiol. 2016 Sep;54(9):2294-7
pubmed: 27335150
Clin Microbiol Infect. 2013 Oct;19(10):E451-3
pubmed: 23663225
Euro Surveill. 2017 Apr 6;22(14):
pubmed: 28422005
Euro Surveill. 2009 Dec 17;14(50):
pubmed: 20070936
J Clin Microbiol. 2010 Sep;48(9):3338-9
pubmed: 20592138
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Vector Borne Zoonotic Dis. 2011 Nov;11(11):1417-23
pubmed: 21767160
Parasit Vectors. 2015 Aug 13;8:418
pubmed: 26265490
Emerg Infect Dis. 2018 May;24(5):875-878
pubmed: 29664365
Euro Surveill. 2013 Sep 19;18(38):
pubmed: 24084339
J Clin Microbiol. 2001 May;39(5):1922-7
pubmed: 11326014
J Neurovirol. 2015 Feb;21(1):92-7
pubmed: 25361698
J Clin Virol. 2018 Oct;107:38-47
pubmed: 30176404
J Infect Dis. 2013 Oct 1;208(7):1086-92
pubmed: 23821721
Euro Surveill. 2017 Oct;22(41):
pubmed: 29043962
Infect Genet Evol. 2017 Jul;51:255-262
pubmed: 28341546
Emerg Infect Dis. 2013 Feb;19(2):274-7
pubmed: 23347844
Vector Borne Zoonotic Dis. 2017 Sep;17(9):658-661
pubmed: 28759350
Emerg Infect Dis. 2002 Jul;8(7):652-6
pubmed: 12095429
Euro Surveill. 2018 Oct;23(43):
pubmed: 30376913
J Clin Virol. 2011 Mar;50(3):221-3
pubmed: 21156352
Euro Surveill. 2012 Dec 13;17(50):
pubmed: 23241231
Euro Surveill. 2009 Dec 17;14(50):
pubmed: 20070935
Euro Surveill. 2012 Sep 06;17(36):20260
pubmed: 22971328
PLoS One. 2012;7(2):e32604
pubmed: 22389712
Clin Infect Dis. 2013 Oct;57(8):1114-28
pubmed: 23861361
Methods Mol Biol. 2014;1079:131-46
pubmed: 24170399
J Med Virol. 2018 Oct;90(10):1666-1668
pubmed: 29797606
Clin Microbiol Infect. 2017 Jan;23(1):33-37
pubmed: 27677699
Vet Microbiol. 2010 Feb 24;141(1-2):159-63
pubmed: 19720475

Auteurs

Monia Pacenti (M)

Microbiology and Virology Unit, Padua University Hospital, Padova, Italy.
These authors contributed equally as first authors.

Alessandro Sinigaglia (A)

These authors contributed equally as first authors.
Department of Molecular Medicine, University of Padova, Padova, Italy.

Thomas Martello (T)

These authors contributed equally as first authors.

Maria Elena De Rui (ME)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Elisa Franchin (E)

These authors contributed equally as first authors.
Department of Molecular Medicine, University of Padova, Padova, Italy.

Silvana Pagni (S)

These authors contributed equally as first authors.
Department of Molecular Medicine, University of Padova, Padova, Italy.

Elektra Peta (E)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Silvia Riccetti (S)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Adelaide Milani (A)

Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro PD, Italy.

Fabrizio Montarsi (F)

Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro PD, Italy.

Gioia Capelli (G)

Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro PD, Italy.

Carlo Giovanni Doroldi (CG)

Medicine Unit, Camposampiero Hospital, Azienda ULSS 6 Euganea, Padova, Italy.

Francesco Bigolin (F)

Medicine Unit, Camposampiero Hospital, Azienda ULSS 6 Euganea, Padova, Italy.

Luca Santelli (L)

Neurology Department, Ospedale S. Antonio, Azienda ULSS 6 Euganea, Padova, Italy.

Lucia Nardetto (L)

Neurology Department, Ospedale S. Antonio, Azienda ULSS 6 Euganea, Padova, Italy.

Marco Zoccarato (M)

Neurology Department, Ospedale S. Antonio, Azienda ULSS 6 Euganea, Padova, Italy.

Luisa Barzon (L)

These authors contributed equally as first authors.
Department of Molecular Medicine, University of Padova, Padova, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH